Michael L. Johnson

19.6k total citations · 2 hit papers
352 papers, 14.8k citations indexed

About

Michael L. Johnson is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Michael L. Johnson has authored 352 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cardiology and Cardiovascular Medicine, 56 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Psychiatry and Mental health. Recurrent topics in Michael L. Johnson's work include Pharmaceutical Practices and Patient Outcomes (40 papers), Growth Hormone and Insulin-like Growth Factors (39 papers) and Hypothalamic control of reproductive hormones (35 papers). Michael L. Johnson is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (40 papers), Growth Hormone and Insulin-like Growth Factors (39 papers) and Hypothalamic control of reproductive hormones (35 papers). Michael L. Johnson collaborates with scholars based in United States, Canada and United Kingdom. Michael L. Johnson's co-authors include Johannes D. Veldhuis, J. D. Veldhuis, Ali Iranmanesh, Michael O. Thorner, GERMAN LIZARRALDE, Fred Kern, Alan D. Rogol, Rajender R. Aparasu, D Z Braverman and William S. Evans and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael L. Johnson

342 papers receiving 14.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection

1986 807 citations J. D. Veldhuis, Michael L. Johnson profile →
The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations.

1987 473 citations Michael L. Johnson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael L. Johnson	4.5k	2.2k	2.2k	2.0k	1.9k	352	14.8k
Henry Völzke	6.1k 1.3×	3.2k 1.4×	756 0.3×	2.5k 1.2×	3.1k 1.6×	791	22.3k
Wolfgang Rascher	2.1k 0.5×	3.0k 1.3×	3.3k 1.5×	1.5k 0.7×	3.1k 1.6×	536	18.0k
Lawrence S. Phillips	8.2k 1.8×	2.7k 1.2×	617 0.3×	2.3k 1.1×	1.6k 0.8×	281	15.7k
Jens Otto Lunde Jørgensen	12.6k 2.8×	6.4k 2.8×	2.3k 1.1×	3.2k 1.6×	2.9k 1.5×	466	21.5k
Roger G. Evans	1.9k 0.4×	2.4k 1.1×	780 0.4×	3.3k 1.6×	3.7k 1.9×	673	20.7k
Ulrich Keller	2.9k 0.6×	3.4k 1.5×	514 0.2×	2.6k 1.3×	914 0.5×	375	14.2k
Nathan W. Levin	1.8k 0.4×	3.8k 1.7×	1.5k 0.7×	5.3k 2.6×	2.5k 1.3×	533	25.1k
Paul J. Davis	6.3k 1.4×	1.6k 0.7×	472 0.2×	1.1k 0.6×	651 0.3×	481	18.9k
Peter C. O’Brien	3.8k 0.8×	10.9k 4.9×	478 0.2×	4.0k 2.0×	2.5k 1.3×	426	39.8k
Beverley Balkau	7.2k 1.6×	4.3k 1.9×	937 0.4×	2.8k 1.4×	2.8k 1.4×	349	20.1k

Countries citing papers authored by Michael L. Johnson

Since Specialization

Citations

This map shows the geographic impact of Michael L. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Johnson more than expected).

Fields of papers citing papers by Michael L. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Johnson. The network helps show where Michael L. Johnson may publish in the future.

Co-authorship network of co-authors of Michael L. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Johnson. A scholar is included among the top collaborators of Michael L. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Johnson. Michael L. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goyal, RK, Sean D. Candrilli, Susan Abughosh, et al.. (2024). Social Determinants of Health and Other Predictors in Initiation of Treatment with CDK4/6 Inhibitors for HR+/HER2− Metastatic Breast Cancer. Cancers. 16(12). 2168–2168. 1 indexed citations

Chatterjee, Satabdi, et al.. (2024). Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer’s Disease Initiating Cholinesterase Inhibitors. Drugs & Aging. 41(4). 339–355. 1 indexed citations

Johnson, Michael L., Ekere James Essien, Jamie C. Barner, et al.. (2023). A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs & Aging. 40(4). 377–390. 15 indexed citations

Johnson, Michael L., et al.. (2023). Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Patient Education and Counseling. 119. 108073–108073. 4 indexed citations

Bakula, Dana M., et al.. (2023). Parent psychosocial adjustment to inpatient pediatric rehabilitation, and the role of uncertainty and self-care.. Rehabilitation Psychology. 68(2). 146–154. 1 indexed citations

Hutton, George J., et al.. (2023). Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(6). 473–484. 1 indexed citations

Huang, Yinan, Sandeep K. Agarwal, Satabdi Chatterjee, et al.. (2023). Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clinical Rheumatology. 43(1). 103–116. 2 indexed citations

Huang, Yinan, Sandeep K. Agarwal, Hua Chen, et al.. (2023). Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study. Clinical Therapeutics. 45(9). e177–e186. 2 indexed citations

Chatterjee, Satabdi, et al.. (2022). Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study. Drugs & Aging. 39(6). 453–465. 6 indexed citations

10.

Chatterjee, Satabdi, et al.. (2021). Risk of overactive bladder associated with cholinesterase inhibitors in dementia. Journal of the American Geriatrics Society. 70(3). 820–830. 3 indexed citations

11.

Rege, Sanika, Ryan M. Carnahan, Michael L. Johnson, et al.. (2021). Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs & Aging. 38(6). 493–502. 3 indexed citations

12.

Hutton, George J., et al.. (2021). Comparative treatment effectiveness of oral fingolimod and conventional injectable disease‐modifying agents in multiple sclerosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(5). 440–450. 2 indexed citations

13.

Holmes, Holly M., et al.. (2020). <p>Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression</p>. Drug Healthcare and Patient Safety. Volume 12. 23–30. 8 indexed citations

14.

Hutton, George J., et al.. (2020). <p>Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis</p>. Patient Preference and Adherence. Volume 14. 2187–2199. 12 indexed citations

15.

Holmes, Holly M., et al.. (2020). Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study. Journal of General Internal Medicine. 35(7). 2084–2093. 11 indexed citations

16.

Holmes, Holly M., et al.. (2020). Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder. International Journal of Geriatric Psychiatry. 36(5). 684–696. 6 indexed citations

17.

Nelson, James T. & Michael L. Johnson. (2016). Effect of Phenology on Total Available Carbohydrates and Crude Protein in Tobosagrass. 1. 44–46.

18.

Morgan, Robert O., et al.. (2009). VHA pharmacy use in veterans with Medicare drug coverage.. PubMed. 15(3). e1–8. 41 indexed citations

19.

Johnson, Michael L., Kenneth Pietz, David Battleman, & Rebecca J. Beyth. (2004). Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.. PubMed. 10(12). 926–32. 100 indexed citations

20.

Veldhuis, J. D. & Michael L. Johnson. (1990). Contemporary aspects of deconvolution analysis to appraise in vivo neuroendocrine secretory events. Frontiers in Neuroendocrinology. 11(4). 363–383. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact